susceptible
to
anisomycin
-lrb-
10
µg
\/
ml
-rrb-
,
novobiocin
-lrb-
5
µg
\/
ml
-rrb-
,
and
pravastatin
-lrb-
10
µg
\/
ml
-rrb-
.

